Originalartikel 2024

  • Mashayekhi V, Schomisch A, Rasheed S, Aparicio-Puerta E, Risch T, Yildiz D, Koch M, Both S, Ludwig N, Legroux T, Keller A, Müller R, Fuhrmann G, Hoppstädter J, Kiemer AK. 2024. The RNA binding protein IGF2BP2/IMP2 alters the cargo of cancer cell-derived extracellular vesicles supporting tumor-associated macrophages. Cell Commun Signal 22:344

  • Legroux TM, Schymik HS, Gasparoni G, Mohammadi S, Walter J, Libert C, Diesel B, Hoppstädter J, Kiemer AK. 2024. Immunomodulation by glucocorticoid-induced leucine zipper (GILZ) in macrophages: insights into enhanced phagocytosis, protection from pyroptosis, and altered mitochondrial function. Front Immunol 15:1396827

  • Boewe AS, Wrublewsky S, Hoppstädter J, Götz C, Kiemer AK, Menger MD, Laschke MW, Ampofo E. 2024. C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme. Mol Ther Nucleic Acids 35:1 

  • Chanda S, Lepikhov K, Dahlem C, Schymik HS, Hoppstädter J, Geber AK, Wagner K, Kessler SM, Empting M, Kiemer AK. 2024. Gene editing and small molecule inhibitors of the RNA binding protein IGF2BP2/IMP2 show its potential as an anti-cancer drug target. Front Biosci (Landmark ed) 29:41

  • Kuhn T, Aljohmani A, Frank N, Zielke L, Mehanny M, Laschke MW, Koch M, Hoppstädter J, Kiemer AK, Yildiz D, Fuhrmann G. 2024. A cell-free, biomimetic hydrogel based on probiotic membrane vesicles ameliorates wound healing. J Control Rel365:969-980